Evaluation of the Cardio protective Effect of Melatonin in Acute Aluminum Phosphide Poisoning: A Randomized Clinical Trial
Phase 4
- Conditions
- aluminum phosphide poisoning
- Registration Number
- PACTR201911790018554
- Lead Sponsor
- fatma gaber sobeeh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
All admitted cases above 18 years with acute aluminum phosphide poisoning will be included in this study.
Exclusion Criteria
•Cases ingested or exposed to other substances in addition to the phosphide.
•Cases with delayed presentation.
•Cases with pre-exciting disease (e.g. cardiovascular disease, renal
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method oDetermination of troponin I level and Arterial Blood Gases and oLipid peroxidation (LPO) assessment <br>oTotal antioxidant capacity assessment <br>
- Secondary Outcome Measures
Name Time Method •Mortality.<br>•Need for ventilation.<br>•Duration of hospital stay<br>